2017
DOI: 10.1016/j.eurpsy.2017.01.1191
|View full text |Cite
|
Sign up to set email alerts
|

Profile lipid and obesity in patients with Tms to treatment with antipsychotis

Abstract: IntroductionPsychiatric patients tend to have severe metabolic alterations of multifactorial causes, lifestyle, diet, drug use and psychopharmacological treatment, especially antipsychotic drugs which act as risk factors for cardiovascular disease, strokes, infections and complications of diseases basal negatively influencing its evolution and prognosis.ObjectivesRating the profile lipid and the prevalence of obesity in patients registered as disorder mental severe in treatment with antipsychotics.Aims/methods… Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles